Regenerative Adjunct · Skin & Scalp
Exosome Therapy in Seoul
Cell-Free Recovery Support, Layered on Proven Treatment
- Duration
- 20-40 min including the paired procedure (microneedling / laser) the exosome is layered onto
- Sessions
- Skin: per paired-procedure course (e.g. 3 sessions 4-6 wk apart). Scalp AGA: monthly, on top of daily minoxidil + finasteride
- Downtime
- Governed by the paired procedure — typically 1-3 days of erythema
Exosome Therapy in Seoul
Exosome therapy at Delight is a cell-free regenerative adjunct applied after microneedling or laser to support skin texture and scalp recovery — layered on proven treatment, not used on its own. Honest framing: exosomes are a cosmetic-grade ingredient, not an FDA/MFDS-approved drug, the evidence is still preliminary, and the effect is modest. We offer topical and scalp application only — not IV.
- Duration
- 20–40 min (with paired procedure)
- Sessions
- Per paired-procedure course / monthly (scalp)
- Downtime
- 1–3 days (from the paired procedure)
- Peak Result
- Modest; skin texture at month 2–3
Results Over Time
Exosome is a modest adjunct on top of a primary procedure — laser or microneedling for skin, and minoxidil + finasteride for scalp. Expect honest, gradual refinement rather than a standalone transformation.
01Day 0
Redness comes from the primary procedure; exosome offers modest soothing after microchannel creation.
02Days 1–3
Erythema from the paired procedure settles. Exosome may modestly shorten recovery per preliminary data.
03Month 1–2
Paired with fractional CO2 or RF microneedling, mild improvement in skin texture and tone may become visible.
04Post-course (skin)
Small RCT signal: Kwon 2020 reported 32.5% acne-scar improvement vs 19.9% control. Honest, gradual refinement.
05Scalp (AGA)
Scalp change reflects the minoxidil + finasteride base. Exosome is an adjunct on top — non-inferior to PRP (Estupiñán 2025), not superior.
06Long-term
Results depend on ongoing medical maintenance. Exosome offers a modest ceiling, similar to PRP.
Images are AI-generated for illustrative purposes only.
Treatment Process
01Pre-Treatment Check
We review your skin or scalp and confirm exosome is an appropriate adjunct. Exosomes are a cosmetic ingredient, not an FDA-approved drug.
02Paired Procedure + Application
Skin: applied topically after microneedling or fractional laser creates microchannels. Scalp: applied on top of your AGA plan. Absorption relies on the paired procedure.
03Post-Care & Recovery
Redness stems from the primary procedure; exosome offers modest soothing. A home-care protocol is provided.
04Expected Outcome
Modest, gradual results that depend on continued medical maintenance — realistic, evidence-framed expectations, never 'regrow' or 'miracle' claims.
Recovery & Care
First 24 hours
Bland emollients + SPF 50+. Avoid heat, sweat, and alcohol for 24–48 hours. For scalp, avoid shampooing for 12 hours.
Days 1–3
Continue emollient and SPF care. Avoid retinoids, AHA/BHA, and vitamin C for 5–7 days. Resume minoxidil on Day 2.
Days 3–14
Let the paired-procedure healing complete. Follow the home-care protocol and resume normal skincare after Day 7–10.
Between sessions
Space visits 4–6 weeks for skin or monthly for scalp. Maintain baseline minoxidil + finasteride for AGA.
Frequently Asked Questions
Q.Is exosome FDA-approved?
No. FDA has approved ZERO exosome products for any indication. Globally registered as COSMETIC ingredient. FDA issued a Public Safety Notification (Dec 2019) and a public safety alert on the marketing of unapproved exosome products, and has taken enforcement action against unapproved exosome marketers. 'FDA-approved exosome' marketing is factually incorrect.
Q.Is exosome the same as stem cell therapy?
No. Exosomes are 30-150 nm extracellular vesicles — cell-free byproducts of MSC culture, NOT live cells. Regulatory categories and mechanisms differ. Calling exosome 'stem cell therapy' is biologically and regulatorily misleading.
Q.Do you offer IV exosome?
No. We offer exosome topically and on the scalp only — never intravenously. IV exosome has no therapeutic evidence base, carries FDA enforcement actions, and a documented bacterial infection cluster, so we would not recommend it at any clinic.
Q.Does exosome replace minoxidil and finasteride?
No. First-line AGA is minoxidil 5% + finasteride 1 mg (Chen 2020). Exosome scalp adjunct is preliminary (non-inferior to PRP, 'data lacking' per Kost 2022). Exosome sits on top of established therapy, never replaces it.
Q.Exosome vs PRP?
PRP is autologous (your own blood). Exosome is allogeneic (donor MSC culture). Estupiñán 2025 split-face: exosome NON-INFERIOR to PRP, not superior. Counterfeit Korean exosome circulates internationally, so we source with direct-distribution documentation.
Q.One-trip exosome course?
Single-session skin protocols viable in a 3-day trip. Full 5-session scalp AGA course requires monthly intervals × 5 months — NOT single-trip and cannot be compressed.
Q.Most serious risks?
(1) IV / systemic injection sterility — FDA enforcement + bacterial infection cluster. (2) Hypersensitivity to MSC-derived material. (3) Counterfeit product without verifiable sterility.
Q.Why cosmetic registration, not drug?
No exosome product has completed the multi-phase RCT efficacy / safety data required for drug approval. Cosmetic pathway permits topical application without that data. Until drug-grade RCT data is filed, exosome remains cosmetic-pathway.
Q.Realistic improvement?
Modest, on top of baseline therapy. Acne scars: 12.6 percentage point delta vs control (Kwon 2020). Photoaging: GAIS improvement (Park 2023, subjective scale). Hair: non-inferior to PRP. We do NOT use 'regrow' / 'cure' / 'permanent' / 'miracle' language.
Q.Safety — systematic review evidence?
Topical safety signal is more favorable than IV. Total exposed-patient count is small. Queen & Avram 2024: 9 alopecia studies, 125 patients, 10 serious adverse events across broader dermatology literature.
Q.Pricing in Seoul?
Exosome is offered as an adjunct, so the cost depends on the paired procedure and the course. Delight's exosome options (for example Youtheal Exosome MTS and Exosome ASCE+) are shown on the pricing page, and exact pricing is confirmed at consultation.
Q.Exosome for melasma?
Only as an adjunct with preliminary evidence — never as a standalone. The foundation for melasma remains topical therapy, strict SPF, and trigger avoidance; exosome sits on top of that, if appropriate.
Q.Why does Delight frame exosome so cautiously?
Because the RCT base is small, effect sizes are modest, and there is no drug approval. We offer exosome as an honest adjunct with realistic expectations rather than as a miracle cure, we don't offer IV exosome, and we build the plan around proven first-line treatment.
References18
The clinical claims on this page — device specs, efficacy timelines, safety profile — are supported by the primary sources below. Each citation links to the original paper or regulatory record.
- [1]Exosome biogenesis, composition, and therapeutic potential — current state. Int J Mol Sci (Krylova) (2023).
- [2]Mesenchymal stromal cell-derived extracellular vesicles — biogenesis and therapeutic application review. Cells (Hade) (2021).
- [3]Topical penetration of UCB-MSC exosome — Korean evidence base. Cytotherapy (Kim) (2017).
- [4]ADSC-Exos rescue UVB photoaging — MMP-1 and MMP-3 suppression preclinical. Stem Cell Res Ther (Liang) (2020).
- [5]ADSC-Exos + fractional CO2 for atrophic acne scars — Korean RCT n=25 (32.5% vs 19.9% p<0.01). Acta Derm Venereol (Kwon) (2020).
- [6]ADSC-Exos + microneedling for photoaging — Korean RCT n=28 GAIS improvement p=0.005. J Cosmet Dermatol (Park) (2023).
- [7]hUCMSC-Exos with microneedling / laser for melasma — clinical study n=60, 4-group. Lasers Surg Med (Wang T et al.) (2022).
- [8]Exosome split-face trial vs PRP for androgenetic alopecia — NON-INFERIOR (not superior). J Cosmet Dermatol (Estupiñán) (2025).
- [9]Exosome for hair loss — narrative review concludes 'data lacking'. Skin Appendage Disord (Kost) (2022).
- [10]Exosome for androgenetic alopecia — 15 preclinical + 1 clinical study systematic review. J Cosmet Dermatol (Gupta) (2023).
- [11]Exosome in dermatology — 9 alopecia studies + 125 patients + 10 serious adverse events. Dermatol Surg (Queen & Avram) (2024).
- [12]Minoxidil + finasteride combination superiority for androgenetic alopecia — RCT evidence. J Am Acad Dermatol (Chen) (2020).
- [13]Microneedling + minoxidil superior to minoxidil alone for AGA — meta-analysis. J Cosmet Dermatol (Abdi) (2023).
- [14]MISEV2023 — ISEV minimal information for extracellular vesicle characterization (international gold-standard criteria). J Extracell Vesicles (Welsh ISEV) (2024).
- [15]ISEV position paper on mesenchymal stromal cell EV-based therapeutics — foundational regulatory framework. J Extracell Vesicles (Lener ISEV) (2015).
- [16]FDA Public Safety Notification on Stem Cell and Exosome Products — December 2019. US FDA (Safety Notification) (2019).
- [17]FDA Public Safety Alert — marketing of unapproved stem cell and exosome products (FDA enforcement basis). US FDA (Public Safety Alert) (2019).
- [18]FDA Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — documents the Nebraska adverse-event cluster. US FDA (Consumer Alert) (2020).
Notice
- Pregnancy or breastfeeding
- Active skin infection or HSV at the site
- Active skin malignancy, autoimmune flare, or systemic immunosuppression
- Expectation of a standalone cure — exosome is an adjunct, reviewed honestly at consultation
- Counterfeit-product concern from prior overseas exosome — clinical safety review at consult
Session summary & comparison
| Item | Details |
|---|---|
| Duration | 20-40 min including the paired procedure (microneedling / laser) the exosome is layered onto |
| Sessions | Skin: per paired-procedure course (e.g. 3 sessions 4-6 wk apart). Scalp AGA: monthly, on top of daily minoxidil + finasteride |
| Downtime | Governed by the paired procedure — typically 1-3 days of erythema |
| Peak result | Modest; skin texture at month 2-3, scalp change reflects the underlying minoxidil + finasteride base |
Related procedures
Evidence & comparison guides
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step